Physician profile
Puneet Panda
NPI 1073827895
$185,246.13
in general payments reported to CMS, 2019-2025
23 companies · $32K in 2025
The $32K reported for 2025 was more than what 98% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $442 · 2021: $37K · 2022: $50K · 2023: $32K · 2024: $32K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $26K · Travel and Lodging: $10K · Food and Beverage: $7,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53,460.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $26,075.00 |
| Travel and Lodging | $10,241.17 |
| Food and Beverage | $7,500.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $161,998.24 | 2019-2025 | Cequa |
| Oyster Point Pharma, INC. | $19,328.37 | 2022-2025 | Tyrvaya |
| Harrow Eye, LLC | $829.47 | 2024-2025 | Vevye |
| Kala Pharmaceuticals, INC. | $409.63 | 2019-2022 | |
| Alcon Vision LLC | $348.14 | 2023-2025 | Argos, Clareon, Rocklatan |
| Tarsus Pharmaceuticals, INC. | $318.00 | 2024-2025 | Xdemvy |
| New World Medical,INC. | $267.22 | 2023-2024 | Clearpath, Streamline, Kahook Dual Blade |
| Dompe US, INC. | $264.92 | 2019-2025 | Oxervate |
| Abbvie INC. | $229.00 | 2022-2025 | |
| Thea Pharma INC. | $222.21 | 2023-2024 | Iyuzeh |
| Bausch & Lomb Americas INC. | $215.44 | 2022-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $173.64 | 2019-2021 | |
| Allergan, INC. | $163.33 | 2019-2022 | |
| Biotissue Holdings INC. | $134.34 | 2019-2023 | |
| Glaukos Corporation | $127.52 | 2024 | Ce-Marked Kxla System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $59.23 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Novartis Pharmaceuticals Corporation | $41.26 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $30.18 | 2024 | Tecnis Iol |
| Eyevance Pharmaceuticals LLC | $24.25 | 2023 | Flarex |
| Sight Sciences, INC. | $18.12 | 2022 | |
| Amgen INC. | $16.84 | 2024 | Tepezza |
| Alcon Research LLC | $15.47 | 2019 | |
| Quidel Corporation | $11.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Puneet Panda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.